(Total Views: 192)
Posted On: 03/11/2020 4:06:30 PM
Post# of 112
NetworkNewsBreaks – MCTC Holdings, Inc. (MCTC) Begins Organization of Animal Study Focused on THC-V and Appetite Suppression, Weight Loss
MCTC Holdings (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, seeks to answer a pressing question within the cannabinoid industry arena: Does tetrahydrocannabivarin (“THC-V”) promote weight loss? According to the update, MCTC has completed Phase One of its Project Varin, a program designed to develop delivery systems and uses for THC-V, and is moving into its second phase of research. Company researchers are now organizing what is believed to be the industry’s first animal study specifically focused on determining if the administration of THC-V leads to appetite suppression and/or weight loss. “While many in the hemp extract and cannabinoid industry openly discuss the potential for THC-V as an aid to appetite suppression and weight loss, there has yet to be any studies specifically designed to validate such statements,” MCTC Holdings CEO Arman Tabatabaei said in the news release. “We plan to use several internally developed delivery systems in a diet-induced obesity model (‘DIO’) utilizing C57 Black 6 male mice. These delivery systems will include our internally developed patent pending nanoparticle and fiber technologies, and our patent pending 100% natural infusion technologies originally developed for cannabidiol (‘CBD’), which will now be applied to THC-V.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
MCTC Holdings (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, seeks to answer a pressing question within the cannabinoid industry arena: Does tetrahydrocannabivarin (“THC-V”) promote weight loss? According to the update, MCTC has completed Phase One of its Project Varin, a program designed to develop delivery systems and uses for THC-V, and is moving into its second phase of research. Company researchers are now organizing what is believed to be the industry’s first animal study specifically focused on determining if the administration of THC-V leads to appetite suppression and/or weight loss. “While many in the hemp extract and cannabinoid industry openly discuss the potential for THC-V as an aid to appetite suppression and weight loss, there has yet to be any studies specifically designed to validate such statements,” MCTC Holdings CEO Arman Tabatabaei said in the news release. “We plan to use several internally developed delivery systems in a diet-induced obesity model (‘DIO’) utilizing C57 Black 6 male mice. These delivery systems will include our internally developed patent pending nanoparticle and fiber technologies, and our patent pending 100% natural infusion technologies originally developed for cannabidiol (‘CBD’), which will now be applied to THC-V.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
